Skip to main content
Top
Published in: Endocrine Pathology 1/2008

01-04-2008

Immunoexpression of Androgen Receptor in the Nontumorous Pituitary and in Adenomas

Authors: Bernd W. Scheithauer, Kalman Kovacs, Suzan Zorludemir, Ricardo V. Lloyd, Seyda Erdogan, Jeffrey Slezak

Published in: Endocrine Pathology | Issue 1/2008

Login to get access

Abstract

Little information is available regarding androgen receptor immunoexpression (AR) in the normal and neoplastic human pituitary. Available experimental data links it to primarily gonadotroph cells. We undertook an immunohistochemical study of 41 autopsy-derived normal glands from patients of both sexes and all ages as well as 79 fully characterized pituitary adenomas of all types, the focus being upon AR expression in normal and neoplastic gonadotrophs. Nuclear AR immunoreactivity was noted in gonadotrophs and other normal adeno- and neurohypophysial cells. In addition to its presence in 74% of gonadotroph and 55% of null cell adenomas, lesser proportions of other adenoma types (adrenocorticotropic hormone 50%, prolactin 38%, growth hormone 33%) also exhibited AR immunoreactivity. No staining of thyroid-stimulating hormone adenomas was noted. The physiologic significance of our findings remains to be explored. The literature regarding AR expression in animal and human pituitaries is reviewed.
Literature
1.
go back to reference Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4–2B prostate cancer cells. Cancer Res. 2006;66(20):10064–72.PubMedCrossRef Bhuiyan MM, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, Sarkar FH. Down-regulation of androgen receptor by 3,3′-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4–2B prostate cancer cells. Cancer Res. 2006;66(20):10064–72.PubMedCrossRef
2.
go back to reference Gao S, Wang H, Lee P, Melamed J, Li CX, Zhang F, Wu H, Zhou L, Wang Z. Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol. 2006;36(3):463–83.PubMedCrossRef Gao S, Wang H, Lee P, Melamed J, Li CX, Zhang F, Wu H, Zhou L, Wang Z. Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol. 2006;36(3):463–83.PubMedCrossRef
3.
go back to reference Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Prostate. 2007;67(5):521–35.PubMedCrossRef Tepper CG, Vinall RL, Wee CB, Xue L, Shi XB, Burich R, Mack PC, de Vere White RW. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Prostate. 2007;67(5):521–35.PubMedCrossRef
4.
go back to reference Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem. 2006;99(2):392–401.PubMedCrossRef Wu JD, Haugk K, Woodke L, Nelson P, Coleman I, Plymate SR. Interaction of IGF signaling and the androgen receptor in prostate cancer progression. J Cell Biochem. 2006;99(2):392–401.PubMedCrossRef
5.
go back to reference Planz B, Wang Q, Kirley SD, Marberger M, McDougal WS. Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate. J Urol. 2001;166 (2):678–83.PubMedCrossRef Planz B, Wang Q, Kirley SD, Marberger M, McDougal WS. Regulation of keratinocyte growth factor receptor and androgen receptor in epithelial cells of the human prostate. J Urol. 2001;166 (2):678–83.PubMedCrossRef
6.
go back to reference Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Forti G, De Chiara G, Lucibello M, Mongiat M, Iozzo RV, Garaci E, Cozzolino F, Torcia MG. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. Prostate. 2002;53(4):310–21.PubMedCrossRef Rosini P, Bonaccorsi L, Baldi E, Chiasserini C, Forti G, De Chiara G, Lucibello M, Mongiat M, Iozzo RV, Garaci E, Cozzolino F, Torcia MG. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation. Prostate. 2002;53(4):310–21.PubMedCrossRef
7.
go back to reference Schafer W, Funke PJ, Kunde D, Rausch U, Wennemuth G, Stutzer H. Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator: correlation with clinical data of long-term observations. J Urol. 2006;176(2):532–37.PubMedCrossRef Schafer W, Funke PJ, Kunde D, Rausch U, Wennemuth G, Stutzer H. Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator: correlation with clinical data of long-term observations. J Urol. 2006;176(2):532–37.PubMedCrossRef
8.
go back to reference Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993;41(5):671–78.PubMed Kimura N, Mizokami A, Oonuma T, Sasano H, Nagura H. Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues. J Histochem Cytochem. 1993;41(5):671–78.PubMed
9.
go back to reference Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev. 1990;11(1):177–99.PubMed Gharib SD, Wierman ME, Shupnik MA, Chin WW. Molecular biology of the pituitary gonadotropins. Endocr Rev. 1990;11(1):177–99.PubMed
10.
go back to reference Wehrenberg WB, Giustina A. Basic counterpoint: mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr Rev. 1992;13(2):299–308.PubMedCrossRef Wehrenberg WB, Giustina A. Basic counterpoint: mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr Rev. 1992;13(2):299–308.PubMedCrossRef
11.
go back to reference Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997;57(20):4511–16.PubMed Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997;57(20):4511–16.PubMed
12.
go back to reference Wang PH, Chang C. Androgens and ovarian cancers. Eur J Gynaecol Oncol. 2004;25(2):157–63.PubMed Wang PH, Chang C. Androgens and ovarian cancers. Eur J Gynaecol Oncol. 2004;25(2):157–63.PubMed
13.
go back to reference Brys M, Semczuk A, Baranowski W, Jakowicki J, Krajewska WM. Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry. Anticancer Res. 2002;22(2A):1025–31.PubMed Brys M, Semczuk A, Baranowski W, Jakowicki J, Krajewska WM. Androgen receptor (AR) expression in normal and cancerous human endometrial tissues detected by RT-PCR and immunohistochemistry. Anticancer Res. 2002;22(2A):1025–31.PubMed
14.
go back to reference Moinfar F, Regitnig P, Tabrizi AD, Denk H, Tavassoli FA. Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Arch. 2004;444(5):410–14.PubMedCrossRef Moinfar F, Regitnig P, Tabrizi AD, Denk H, Tavassoli FA. Expression of androgen receptors in benign and malignant endometrial stromal neoplasms. Virchows Arch. 2004;444(5):410–14.PubMedCrossRef
15.
go back to reference Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM. Androgen receptor expression in meningiomas. J Neurosurg. 1995;82(3):453–60.PubMed Carroll RS, Zhang J, Dashner K, Sar M, Wilson EM, Black PM. Androgen receptor expression in meningiomas. J Neurosurg. 1995;82(3):453–60.PubMed
16.
go back to reference Weisenberg LS, Piroli G, Heller CL, De Nicola AF. Binding of steroids in nuclear extracts and cytosol of rat pituitary and estrogen-induced pituitary tumors. J Steroid Biochem. 1987;28(6):683–89.PubMedCrossRef Weisenberg LS, Piroli G, Heller CL, De Nicola AF. Binding of steroids in nuclear extracts and cytosol of rat pituitary and estrogen-induced pituitary tumors. J Steroid Biochem. 1987;28(6):683–89.PubMedCrossRef
17.
go back to reference Jaffrain-Rea ML, Petrangeli E, Ortolani F, Fraioli B, Lise A, Esposito V, Spagnoli LG, Tamburrano G, Frati L, Gulino A. Cellular receptors for sex steroids in human pituitary adenomas. J Endocrinol. 1996;151(2):175–84.PubMedCrossRef Jaffrain-Rea ML, Petrangeli E, Ortolani F, Fraioli B, Lise A, Esposito V, Spagnoli LG, Tamburrano G, Frati L, Gulino A. Cellular receptors for sex steroids in human pituitary adenomas. J Endocrinol. 1996;151(2):175–84.PubMedCrossRef
18.
go back to reference Caronti B, Palladini G, Calderaro C, Bevilacqua MG, Petrangeli E, Esposito V, Tamburrano G, Gulino A, Jaffrain-Rea ML. Effects of gonadal steroids on the growth of human pituitary adenomas in vitro. Tumour Biol. 1995;16(6):353–64.PubMed Caronti B, Palladini G, Calderaro C, Bevilacqua MG, Petrangeli E, Esposito V, Tamburrano G, Gulino A, Jaffrain-Rea ML. Effects of gonadal steroids on the growth of human pituitary adenomas in vitro. Tumour Biol. 1995;16(6):353–64.PubMed
19.
go back to reference Saeger W, Schreiber S, Ludecke DK. Androgen receptor in pituitary adenomas of the gonadotroph cell complex. Pathol Res Pract. 2000;196(11):771–73.PubMed Saeger W, Schreiber S, Ludecke DK. Androgen receptor in pituitary adenomas of the gonadotroph cell complex. Pathol Res Pract. 2000;196(11):771–73.PubMed
20.
go back to reference Babichev VN, Marova EI, Kuznetsova TA, Adamskaya EI, Shishkina IV, YuK S. Role of sex hormones in development of pituitary adenoma. Bull Exp Biol Med. 2001;131(4):309–11.PubMedCrossRef Babichev VN, Marova EI, Kuznetsova TA, Adamskaya EI, Shishkina IV, YuK S. Role of sex hormones in development of pituitary adenoma. Bull Exp Biol Med. 2001;131(4):309–11.PubMedCrossRef
21.
go back to reference Asa SL. Tumors of the pituitary gland. In: Rosai J, editor. Atlas of tumor pathology, 3rd series, fascicle 22. Washington, DC: Armed Forces Institute of Pathology; 1998; p 1–210. Asa SL. Tumors of the pituitary gland. In: Rosai J, editor. Atlas of tumor pathology, 3rd series, fascicle 22. Washington, DC: Armed Forces Institute of Pathology; 1998; p 1–210.
22.
go back to reference Choate JV, Slayden OD, Resko JA. Immunocytochemical localization of androgen receptors in brains of developing and adult male rhesus monkeys. Endocrine. 1998;8(1):51–60.PubMedCrossRef Choate JV, Slayden OD, Resko JA. Immunocytochemical localization of androgen receptors in brains of developing and adult male rhesus monkeys. Endocrine. 1998;8(1):51–60.PubMedCrossRef
23.
go back to reference Woods JE, Blandin CM, Thommes RC. Ontogeny of immunocytochemically demonstrable androgen- and androgen receptor-containing cells in the hypothalamus and adenohypophysis of the chick embryo. Growth Dev Aging. 1994;58(1):21–31.PubMed Woods JE, Blandin CM, Thommes RC. Ontogeny of immunocytochemically demonstrable androgen- and androgen receptor-containing cells in the hypothalamus and adenohypophysis of the chick embryo. Growth Dev Aging. 1994;58(1):21–31.PubMed
24.
go back to reference Okada Y, Fujii Y, Moore JP, Jr., Winters SJ. Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology. 2003;144(1):267–73.PubMedCrossRef Okada Y, Fujii Y, Moore JP, Jr., Winters SJ. Androgen receptors in gonadotrophs in pituitary cultures from adult male monkeys and rats. Endocrinology. 2003;144(1):267–73.PubMedCrossRef
25.
go back to reference Prior JC, Cox TA, Fairholm D, Kostashuk E, Nugent R. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab. 1987;64(2):391–94.PubMed Prior JC, Cox TA, Fairholm D, Kostashuk E, Nugent R. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J Clin Endocrinol Metab. 1987;64(2):391–94.PubMed
26.
go back to reference Lopes MBS, Thapar K, Horvath E, Kovacs K. Neoplasms of the sellar region (chap 54). In: McLendon RE, Rosenblum MK, Bigner DD, editors. Russell and Rubinstein’s pathology of tumors of the nervous system, 7th edn. New York, NY: Hodder Arnold; 2006. p. 740–741. Lopes MBS, Thapar K, Horvath E, Kovacs K. Neoplasms of the sellar region (chap 54). In: McLendon RE, Rosenblum MK, Bigner DD, editors. Russell and Rubinstein’s pathology of tumors of the nervous system, 7th edn. New York, NY: Hodder Arnold; 2006. p. 740–741.
27.
go back to reference DonCarlos LL, Sarkey S, Lorenz B, Azcoitia I, Garcia-Ovejero D, Huppenbauer C, Garcia-Segura LM. Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience. 2006;138(3):801–807.PubMedCrossRef DonCarlos LL, Sarkey S, Lorenz B, Azcoitia I, Garcia-Ovejero D, Huppenbauer C, Garcia-Segura LM. Novel cellular phenotypes and subcellular sites for androgen action in the forebrain. Neuroscience. 2006;138(3):801–807.PubMedCrossRef
28.
go back to reference Lorenz B, Garcia-Segura LM, DonCarlos LL. Cellular phenotype of androgen receptor-immunoreactive nuclei in the developing and adult rat brain. J Comp Neurol. 2005;492(4):456–68.PubMedCrossRef Lorenz B, Garcia-Segura LM, DonCarlos LL. Cellular phenotype of androgen receptor-immunoreactive nuclei in the developing and adult rat brain. J Comp Neurol. 2005;492(4):456–68.PubMedCrossRef
29.
go back to reference Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol. 2002;450(3):256–71.PubMedCrossRef Garcia-Ovejero D, Veiga S, Garcia-Segura LM, Doncarlos LL. Glial expression of estrogen and androgen receptors after rat brain injury. J Comp Neurol. 2002;450(3):256–71.PubMedCrossRef
30.
go back to reference Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L. Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci. 2001;19(1):11–19.PubMedCrossRef Hosli E, Jurasin K, Ruhl W, Luthy R, Hosli L. Colocalization of androgen, estrogen and cholinergic receptors on cultured astrocytes of rat central nervous system. Int J Dev Neurosci. 2001;19(1):11–19.PubMedCrossRef
31.
go back to reference Puy L, MacLusky NJ, Becker L, Karsan N, Trachtenberg J, Brown TJ. Immunocytochemical detection of androgen receptor in human temporal cortex characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol. 1995;55(2):197–209.PubMedCrossRef Puy L, MacLusky NJ, Becker L, Karsan N, Trachtenberg J, Brown TJ. Immunocytochemical detection of androgen receptor in human temporal cortex characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol. 1995;55(2):197–209.PubMedCrossRef
32.
go back to reference Verzat C, Delisle MB, Courriere P, Hollande E. Influence of host sex on the growth of a human glioblastoma line in athymic mice. Neuropathol Appl Neurobiol. 1990;16(2):141–51.PubMedCrossRef Verzat C, Delisle MB, Courriere P, Hollande E. Influence of host sex on the growth of a human glioblastoma line in athymic mice. Neuropathol Appl Neurobiol. 1990;16(2):141–51.PubMedCrossRef
33.
go back to reference Huang X, Harlan RE. Androgen receptor immunoreactivity in somatostatin neurons of the periventricular nucleus but not in the bed nucleus of the stria terminalis in male rats. Brain Res. 1994;652(2):291–96.PubMedCrossRef Huang X, Harlan RE. Androgen receptor immunoreactivity in somatostatin neurons of the periventricular nucleus but not in the bed nucleus of the stria terminalis in male rats. Brain Res. 1994;652(2):291–96.PubMedCrossRef
34.
go back to reference Bittman EL, Ehrlich DA, Ogdahl JL, Jetton AE. Photoperiod and testosterone regulate androgen receptor immunostaining in the Siberian hamster brain. Biol Reprod. 2003;69(3):876–84.PubMedCrossRef Bittman EL, Ehrlich DA, Ogdahl JL, Jetton AE. Photoperiod and testosterone regulate androgen receptor immunostaining in the Siberian hamster brain. Biol Reprod. 2003;69(3):876–84.PubMedCrossRef
35.
go back to reference Iqbal J, Swanson JJ, Prins GS, Jacobson CD. Androgen receptor-like immunoreactivity in the Brazilian opossum brain and pituitary: distribution and effects of castration and testosterone replacement in the adult male. Brain Res. 1995;703(1–2):1–18.PubMed Iqbal J, Swanson JJ, Prins GS, Jacobson CD. Androgen receptor-like immunoreactivity in the Brazilian opossum brain and pituitary: distribution and effects of castration and testosterone replacement in the adult male. Brain Res. 1995;703(1–2):1–18.PubMed
36.
go back to reference Herbison AE. Neurochemical identity of neurones expressing oestrogen and androgen receptors in sheep hypothalamus. J Reprod Fertil Suppl. 1995;49:271–83.PubMed Herbison AE. Neurochemical identity of neurones expressing oestrogen and androgen receptors in sheep hypothalamus. J Reprod Fertil Suppl. 1995;49:271–83.PubMed
37.
go back to reference Wu SS, Nathanielsz PW, McDonald TJ. Immunocytochemical distribution of androgen receptors in the hypothalamus and pituitary of the fetal baboon in late gestation. Dev Brain Res. 1995;84(2):278–81.CrossRef Wu SS, Nathanielsz PW, McDonald TJ. Immunocytochemical distribution of androgen receptors in the hypothalamus and pituitary of the fetal baboon in late gestation. Dev Brain Res. 1995;84(2):278–81.CrossRef
38.
go back to reference Sar M, Stumpf WE. Distribution of androgen target cells in rat forebrain and pituitary after [3H]-dihydrotestosterone administration. J Steroid Biochem. 1977;8(11):1131–35.PubMedCrossRef Sar M, Stumpf WE. Distribution of androgen target cells in rat forebrain and pituitary after [3H]-dihydrotestosterone administration. J Steroid Biochem. 1977;8(11):1131–35.PubMedCrossRef
39.
go back to reference Thieulant ML, Duval J. Differential distribution of androgen and estrogen receptors in rat pituitary cell populations separated by centrifugal elutriation. Endocrinology. 1985;116(4):1299–303.PubMedCrossRef Thieulant ML, Duval J. Differential distribution of androgen and estrogen receptors in rat pituitary cell populations separated by centrifugal elutriation. Endocrinology. 1985;116(4):1299–303.PubMedCrossRef
40.
go back to reference Console GG, Rulli SB, Riccillo FL, Calandra RS, Gomez Dumm CL. Effects of androgens and antiandrogens on the quantitative immunohistochemistry of gonadotrope cells in prepubertal male rats. Neuroendocrinology. 1999;70(4):261–67.PubMedCrossRef Console GG, Rulli SB, Riccillo FL, Calandra RS, Gomez Dumm CL. Effects of androgens and antiandrogens on the quantitative immunohistochemistry of gonadotrope cells in prepubertal male rats. Neuroendocrinology. 1999;70(4):261–67.PubMedCrossRef
41.
go back to reference Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C. Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. J Endocrinol. 1990;126(1):17–25.PubMed Takeda H, Chodak G, Mutchnik S, Nakamoto T, Chang C. Immunohistochemical localization of androgen receptors with mono- and polyclonal antibodies to androgen receptor. J Endocrinol. 1990;126(1):17–25.PubMed
Metadata
Title
Immunoexpression of Androgen Receptor in the Nontumorous Pituitary and in Adenomas
Authors
Bernd W. Scheithauer
Kalman Kovacs
Suzan Zorludemir
Ricardo V. Lloyd
Seyda Erdogan
Jeffrey Slezak
Publication date
01-04-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 1/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-007-9012-0

Other articles of this Issue 1/2008

Endocrine Pathology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine